Sarcoma Research News in ESUN
Links shared publicly online about this topic.
- 827total visits
Sarcoma Research News in ESUN
View full resource at sarcomahelp.org
Most Recently Shared on April 11, 2012 at 1:25 pm By:
Research Corner: abstracts of recent #sarcoma related research articles http://t.co/QEbyFdxf
FDA says Merck's ridaforolimus meets study goal - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Merck & Co Inc's ridaforolimus tablets met their primary research end-point of reducing by 25 percent the risk of progression or death in patients with metastatic soft tissue or bone sarcoma, U.S. health regulators said on Friday. A staff review document released by the Food and Drug Administration also said the treatment known by the brand name Taltorvic showed no new or unexpected safety signals in clinical research. The drug will come before an advisor” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 2:46 pm By:
HealthTrendster Health Executive
FDA says Merck's ridaforolimus meets study goal - WASHINGTON (Reuters) - Merck & Co Inc's ridaforolimus tablets met ... http://t.co/olPZGSSo
FDA says Merck's ridaforolimus meets study goal - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Merck & Co Inc's ridaforolimus tablets met their primary research end-point of reducing by 25 percent the risk of progression or death in patients with metastatic soft tissue or bone sarcoma, U.S. health regulators said on Friday. A staff review document released by the Food and Drug Administration also said the treatment known by the brand name Taltorvic showed no new or unexpected safety signals in clinical research. The drug will come before an advisor” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 2:45 pm By:
FDA says Merck's ridaforolimus meets study goal: WASHINGTON (Reuters) - Merck & Co Inc's ridaforolimus tablets m... http://t.co/y7DvS2Cd
Using rat stem cells to study Kaposi’s sarcoma virus - National Cancer Institute
cancer.gov — “To understand a virus that causes cancer — and ultimately learn how to beat it — scientists must be able to infect a healthy cell with the virus, keep that cell alive and transform it into a cancerous cell. Scientists at the University of Southern Califor” View full resource at cancer.gov
Most Recently Shared on February 3, 2012 at 5:24 pm By:
in @USCHealthNews, researchers use rat stem cells to study #Kaposi #sarcoma virus http://t.co/ilQbbiqZ #cancer
Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center
news-medical.net — “Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.” View full resource at news-medical.net
Most Recently Shared on December 7, 2011 at 12:59 pm By:
Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center: Aethlon Medical, Inc., the pio... http://t.co/I9Pdn6sn
Promising new agent against sarcomas affecting children
news-medical.net — “MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla. Their findings, recently appearing in Molecular Cancer Therapeutics, published by the American Association for Cancer Research, suggest that a badly needed new agent against sarcomas - especially sarcomas affecting children - may be at hand.” View full resource at news-medical.net
Most Recently Shared on December 3, 2011 at 9:26 am By:
Cancer News Promising new agent against sarcomas affecting children: MK 1775, a small, selective inhibitor molec... http://t.co/VCXcQeU4
Medical News: Rare-Cancer Charity Founder Dies at 40 - in Oncology, Other Cancers from MedPage Today
medpagetoday.com — “Jennifer Goodman Linn, founder of the rare-cancer-research charity Cycle for Survival, died last month after a seven-year battle with sarcoma. She was 40.” View full resource at medpagetoday.com
Most Recently Shared on August 11, 2011 at 5:46 pm By:
Rare-Cancer Charity Founder Dies at 40 http://bit.ly/rnNO6Y
Researchers Discover Possible New Target for Sarcoma Treatment and Prevention
newswise.com — “Researchers from Mount Sinai School of Medicine have discovered a protein signaling pathway that becomes hyperactivated in human sarcoma cells, suggesting that medications to inhibit this pathway may be effective in the treatment of human sarcomas. The research is published in the current issue of the journal Cancer Cell.” View full resource at newswise.com
Most Recently Shared on May 23, 2011 at 4:47 pm By:
#health news: Researchers Discover Possible New Target for Sarcoma Treatment and Prevention: Researchers from Mo... http://bit.ly/m5tP5D
Sea sponge-derived drug treats several cancers | Reuters
reuters.com — “WASHINGTON (Reuters) - An experimental new breast cancer drug made from sea sponges helped in a range of cancers, from breast cancer to sarcoma, researchers report. Three studies show the drug, Eisai's” View full resource at reuters.com
Most Recently Shared on May 21, 2010 at 10:02 pm By:
Sea sponge-derived drug treats several cancers: WASHINGTON (Reuters) - An experimental new breast can... http://bit.ly/9khSQ0 #health #news
Oncology Medical News about Breast Neoplasms Head and Neck Neoplasms Melanoma Ovarian Neoplasms Soft Tissue Neoplasms
mdlinx.com — “Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)” View full resource at mdlinx.com
Most Recently Shared on May 21, 2010 at 12:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advance... http://bit.ly/9XkefV #oncology
Well-characterized molecular alterations of sarcomas make them ideal models for developing new therapies
news-medical.net — “New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors.” View full resource at news-medical.net
Most Recently Shared on March 9, 2010 at 6:54 am By:
Well-characterized molecular alterations of sarcomas make them ideal models for developing new therapies: New brea... http://bit.ly/dAFNyn
New Treatment Eyed for Ewing's Sarcoma - Drugs.com MedNews
drugs.com — “Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing s sarcoma, a cancer that affects the areas in and n” View full resource at drugs.com
Most Recently Shared on December 25, 2009 at 11:41 pm By:
New Treatment Eyed for Ewing's Sarcoma - http://bit.ly/5kNzmc
New Treatment Eyed for Ewing's Sarcoma - myOptumHealth
myoptumhealth.com — “Read the news article New Treatment Eyed for Ewing's Sarcoma at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on December 24, 2009 at 7:14 am By:
New Treatment Eyed for Ewing's Sarcoma: Figitumumab fights tumors and appears to be well-tolerated, researchers say http://bit.ly/6fX2OO
Medical News: Young Cancer Survivors May Risk Late Recurrence - in Hematology/Oncology, Hematology from MedPage Today
medpagetoday.com — “Survivors of some pediatric cancers may be at risk for late recurrence, particularly if they've had Ewing sarcoma or astrocytoma, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on December 10, 2009 at 1:22 am By:
Matthew Zachary Patient Expert
News flash! This week on "Tell us something we don't know" – "Young Cancer Survivors May Risk Late Recurrence" – http://bit.ly/5ICGqS
Medical News: Young Cancer Survivors May Risk Late Recurrence - in Hematology/Oncology, Hematology from MedPage Today
medpagetoday.com — “Survivors of some pediatric cancers may be at risk for late recurrence, particularly if they've had Ewing sarcoma or astrocytoma, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on December 4, 2009 at 10:59 pm By:
Young Cancer Survivors May Risk Late Recurrence (CME/CE) http://bit.ly/4t6vnf
Watch Prof Rolf Issels - University of Munich, Germany, Targeted heat therapy offers new standard treatment option for soft tissue sarcoma on ecancer tv. Cancer journal: online cancer news, clinical oncology research, cancer information and latest cancer
ecancermedicalscience.com — “Watch Prof Rolf Issels - University of Munich, Germany, Targeted heat therapy offers new standard treatment option for soft tissue sarcoma on ecancer tv. Prof Rolf Issels, University of Munich, Germany, speaking at ECCO 15 - ESMO 34 Conference in Berlin, 2009: Targeted heat therapy offers new standard treatment option for soft tissue sarcoma. (A type of treatment in which body tissue is exposed to high temperatures to damage and kill cancer cells or to make cancer cells more sensitive to the eff” View full resource at ecancermedicalscience.com
Most Recently Shared on October 13, 2009 at 9:51 pm By:
Keith Scott-Mumby PhD, Doctor, and CAM
Short video of Prof. Issels presenting his paper on hyperthermia against cancer, Berlin 2009: http://tinyurl.com/ydukcd7
Advertisement
